The market for drugs to treat chronic lymphocytic leukaemia has changed substantially recently with the introduction of novel targeted therapies. This article discusses the treatment landscape and highlights agents in the late-stage pipeline.
机构:
St Thomas Hosp, Guys & St Thomas Hosp Trust, Dept Haematol, London SE1 7EH, EnglandSt Thomas Hosp, Guys & St Thomas Hosp Trust, Dept Haematol, London SE1 7EH, England
Brown, SA
Phillips, J
论文数: 0引用数: 0
h-index: 0
机构:
St Thomas Hosp, Guys & St Thomas Hosp Trust, Dept Haematol, London SE1 7EH, EnglandSt Thomas Hosp, Guys & St Thomas Hosp Trust, Dept Haematol, London SE1 7EH, England
Phillips, J
Ahsan, G
论文数: 0引用数: 0
h-index: 0
机构:
St Thomas Hosp, Guys & St Thomas Hosp Trust, Dept Haematol, London SE1 7EH, EnglandSt Thomas Hosp, Guys & St Thomas Hosp Trust, Dept Haematol, London SE1 7EH, England
Ahsan, G
Slater, NGP
论文数: 0引用数: 0
h-index: 0
机构:
St Thomas Hosp, Guys & St Thomas Hosp Trust, Dept Haematol, London SE1 7EH, EnglandSt Thomas Hosp, Guys & St Thomas Hosp Trust, Dept Haematol, London SE1 7EH, England